Nova Bio-Pharma Technologies Limited – Trademark Portfolio
Entity Type: 99
Nova Bio-Pharma Technologies Limited holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 13 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include HYDRIS and PURIXAN. The owner is based in Leicestershire.
Martin House
Gloucester Crescent, Wigston
Leicestershire LE184YF , GB
Showing of trademarks Trademarks
Trademark Classifications
Nova Bio-Pharma Technologies Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Nova Bio-Pharma Technologies Limited have?
Nova Bio-Pharma Technologies Limited has 13 U.S. trademarks filed with the USPTO. Of these, 2 registered, 8 abandoned, 2 cancelled.
What trademark classes does Nova Bio-Pharma Technologies Limited file in?
Nova Bio-Pharma Technologies Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Nova Bio-Pharma Technologies Limited's most well-known trademarks?
Nova Bio-Pharma Technologies Limited's registered trademark portfolio includes well-known marks such as HYDRIS and PURIXAN. These are among 2 currently registered trademarks in the portfolio.
What is Nova Bio-Pharma Technologies Limited's trademark registration success rate?
Nova Bio-Pharma Technologies Limited has a 17% trademark registration rate, with 2 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.